SARS (severe acute respiratory syndrome) test progress slow: sensitivity the key, says WHO
This article was originally published in Clinica
The development of commercial diagnostic tests for SARS has progressed more slowly than initially hoped," the World Health Organization said this week (June 2 2003). The need for tests with a particularly high sensitivity remains the key challenge for SARS control, says the WHO.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.